Video shots | Highlights and latest updates from ESMO 2024

Dr Axel Merseburger talks to Dr Petros Grivas about the latest NIAGARA data presented at ESMO 2024 and how it informs optimal treatment sequencing for patients with metastatic UC.
This video is part of the Independent Medical Education program entitled "New perspectives in metastatic UC: Novel therapies & effective patient communication". Dr Axel Merseburger joins Dr Enrique Grande to cover the rapid evolution of the treatment landscape of mUC, including recent data updates in first-line, maintenance therapy, and second- and later-treatment lines.
To learn more about the full program, visit new-perspectiv...
This programme is made possible thanks to an educational grant received from Merck Healthcare KGaA, Darmstadt, Germany and Astellas.